Personalized PRRT Significantly and Safely Increased Irradiation of Neuroendocrine Tumors (IMAGE)

Society of Nuclear Medicine and Molecular Imaging

Personalized PRRT Significantly and Safely Increased Irradiation of Neuroendocrine Tumors

Caption

In personalized PRRT (P-PRRT), injected activity of 177Lu-octreotate is adjusted (left panel) to limit renal radiation dose (middle panel) and increase tumor radiation dose (right panel), as compared to empiric, fixed-injected activity (Fixed-IA) PRRT.

Credit

Michela Del Prete and colleagues, CHU de Québec - Université Laval

Usage Restrictions

include title and credit

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.